Advertisement
Home 2015

Archives

Fewer unmarried American men are becoming first-time fathers

CDC: Fewer Single Young Men Becoming First-Time Fathers

0
Rate of first-time dads having child out of wedlock fell from 1980s to 2000s
The prices hospitals charge patients for a number of common procedures rose more than 10 percent between 2011 and 2013

CMS: Hospital Charges for Common Procedures Up

0
And hematologists/oncologists and ophthalmologists top list of high earners
Nearly 30 percent of Americans have a problem with alcohol at some point in their lives

Nearly 3 in 10 Americans Have Alcohol Use Disorder

0
Fewer than 20 percent get help
Nearly one-fifth of teens and younger adults in the United States have been tested recently for HIV

CDC: 1 in 5 U.S. Teens, Younger Adults Tested Recently for HIV

0
Testing rates of those ages 15 to 44: 22 percent for females and 16 percent for males
Patients with HIV should start antiretroviral therapy as soon as they're diagnosed

Greater Benefit for Early Antiretroviral Tx Initiation in HIV

0
NIH-funded trial results appear likely to impact global treatment guidelines
Soft tissue fillers used in cosmetic procedures can be unintentionally injected into blood vessels in the face and cause serious harm

FDA Warns of Soft Tissue Filler Injection Into Blood Vessels

0
When injections accidentally enter blood vessels, blockages and damage can occur
Low physician spending is contributing to an overall slowing of health care costs

AMA: Physicians Driving the Slowing of Health Care Costs

0
Physicians' spending grew more slowly over 2003 to 2013 than hospital and clinical spending
Rapamune (sirolimus) has been approved by the U.S. Food and Drug Administration to treat lymphangioleiomyomatosis

FDA Approves Rapamune for Lymphangioleiomyomatosis

0
Rare, progressive lung disease affects mostly women of child-bearing age
Two new therapies to treat irritable bowel syndrome accompanied by diarrhea in adults have been approved by the U.S. Food and Drug Administration.

FDA: Two Drugs Approved for Irritable Bowel Syndrome

0
U.S. Food and Drug Administration approves Viberzi (eluxadoline) and Xifaxan (rifaximin)
New U.S. government research connects severe vision loss with poverty

CDC: Low-Income Southerners at Highest Risk of Vision Loss

0
Restricted access to eye and health care likely to blame, study authors suggest